1. Home
  2. WIX vs STVN Comparison

WIX vs STVN Comparison

Compare WIX & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wix.com Ltd.

WIX

Wix.com Ltd.

N/A

Current Price

$90.11

Market Cap

4.4B

Sector

Technology

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$15.02

Market Cap

4.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
WIX
STVN
Founded
2006
1949
Country
Israel
Italy
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
4.2B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
WIX
STVN
Price
$90.11
$15.02
Analyst Decision
Strong Buy
Buy
Analyst Count
22
4
Target Price
$156.95
$25.13
AVG Volume (30 Days)
2.5M
636.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
0.41%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.55
$10.26
Revenue Next Year
$13.24
$10.02
P/E Ratio
$28.86
$27.15
Revenue Growth
N/A
N/A
52 Week Low
$60.22
$13.91
52 Week High
$190.92
$28.00

Technical Indicators

Market Signals
Indicator
WIX
STVN
Relative Strength Index (RSI) 63.24 42.55
Support Level $75.00 $14.03
Resistance Level $96.82 $16.69
Average True Range (ATR) 4.71 0.89
MACD 3.60 0.11
Stochastic Oscillator 86.36 25.25

Price Performance

Historical Comparison
WIX
STVN

About WIX Wix.com Ltd.

Wix.com is a software-as-a-service content management system platform that allows users to create, customize, and manage websites for themselves, or for clients. Wix is best known for its Wix Editor service for self-creators, but in recent years has invested heavily and introduced its Wix Studio offering for partners, who are agencies and developers. Wix also offers a range of business solutions such as payment services and marketing products.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: